These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 402327)

  • 1. Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin.
    Grimmer O; Fagerhol MK
    Int J Pept Protein Res; 1977; 9(2):85-90. PubMed ID: 402327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
    Andersson LO; Engman L; Henningsson E
    J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
    Girolami A; Marafioti F; Rubertelli M; Vicarioto MA; Cappellato G; Mazzuccato M
    Acta Haematol; 1984; 72(2):73-82. PubMed ID: 6208738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on antithrombin III in normal plasma and serum.
    Sas G; Pepper DS; Cash JD
    Br J Haematol; 1975 Jul; 30(3):265-72. PubMed ID: 1201212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of properdin in normal human serum by electroimmunoassay and single radial immunodiffusion.
    Persson K; Kindmark CO; Pensky J; Naff G
    Clin Exp Immunol; 1977 Jul; 29(1):84-8. PubMed ID: 408067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
    Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential quantification of SIgA and SC by two-directional rocket method.
    Kosaka T; Asahina T; Kobayashi N
    Immunology; 1980 Aug; 40(4):597-604. PubMed ID: 6776036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple amidolytic method for the determination of functional active antithrombin III.
    Abildaard U; Lie M; Odegård OR
    Scand J Clin Lab Invest; 1976 Jan; 36(1):109-12. PubMed ID: 815998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical requirements for immunochemical analysis of antithrombin III in agarose gels.
    McKay EJ
    Clin Chim Acta; 1981 Nov; 117(1):25-32. PubMed ID: 6800672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of human platelets with heparinized agarose gel.
    Lindon J; Rosenberg R; Merrill E; Salzman E
    J Lab Clin Med; 1978 Jan; 91(1):47-59. PubMed ID: 618990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I
    Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: A method for the quantitative determination of the antithrombin III (AT III) activity in plasma and serum using the complex formation with heparin.
    Karges HE; Heimburger N; Loechelt C
    Thromb Diath Haemorrh; 1975 Sep; 34(1):347. PubMed ID: 1188792
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.
    Corral J; Rivera J; Martínez C; González-Conejero R; Miñano A; Vicente V
    J Lab Clin Med; 2003 Nov; 142(5):298-305. PubMed ID: 14647033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-sepharose affinity chromatography of human post-heparin plasma. Characterization of the elution pattern with immunoelectrophoretic methods.
    Thim L
    Scand J Clin Lab Invest; 1978 Feb; 38(1):77-81. PubMed ID: 75564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.